Acute Myeloid Leukemia with Myelodysplasia-Related Changes (AML-MRC): An Evolving Diagnostic and Therapeutic Paradigm
Joshua F. Zeidner, MD, will discuss the evolving diagnostic algorithm for AML-MRC, prognosis, treatment outcomes, and unmet needs.
Category
  • Research to Practice
Format
  • Self-Paced, Online Courses
Credits
  • 1.00 ACPE Pharmacist
  • 1.00 ACPE Pharmacy Tech
  • 1.00 CTR Category A
  • 1.00 NCPD/CNE
  • 1.00 Participation
Lymphoma Management in North Carolina: Updates for 2023
Natalie Grover, MD, will review some of the recent advances in the treatment of lymphoma, including the incorporation of novel targeted agents in the frontline treatment of diffuse large B cell lymphoma and Hodgkin lymphoma, the use of CAR-T cell therapy in second-line treatment in diffuse large B cell lymphoma, and recently approved drugs by the FDA for lymphoma.
Category
  • Research to Practice
Format
  • Self-Paced, Online Courses
Credits
  • 1.00 ACPE Pharmacist
  • 1.00 ACPE Pharmacy Tech
  • 1.00 ASRT
  • 1.00 CTR Category A
  • 1.00 NCPD/CNE
  • 1.00 Participation